Gut Microbiome Testing Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035)

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Gut Microbiome Testing Market Overview

Gut microbiome testing is gaining importance as advances in sequencing and analytical technologies enable deeper assessment of microbial communities. The growing interest in personalized nutrition, preventive healthcare, and disease research is encouraging the adoption of microbiome-based testing across clinical, research, and wellness settings. The market is expanding with increasing awareness of the relationship between gut health and overall well-being, alongside growing investments in microbiome research and testing technologies. Rising demand for personalized healthcare and improved diagnostic approaches is supporting market development. The market is poised to reach USD 5.97 Billion by 2035.

Gut Microbiome Testing Market Growth Analysis and Key Influencers

Gut Microbiome Testing Market Dynamics

The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.

Gut Microbiome Testing Market Growth Drivers

Expanding Clinical Applications of Microbiome Analysis to Support Market Value

The growing evidence linking gut microbial signatures with disease detection is strengthening demand for microbiome testing. For instance, in June 2026, EMBL-led researchers reanalyzed 6,779 gut microbiome profiles from 27 studies and 906 intestinal tissue samples, identifying a robust colorectal cancer-associated microbial signature across populations, sequencing methods, and age groups. A machine-learning classifier also distinguished colorectal cancer from non-cancer microbiomes. These findings strengthen the potential of microbiome testing for disease research, risk assessment, and future clinical applications, supporting market expansion.

Gut Microbiome Testing Market Restraints

Methodological Variability Limits Market Reliability and Clinical Adoption

Variability in sequencing technologies, laboratory protocols, bioinformatics software, and reference databases can produce inconsistent microbiome test results, limiting clinical confidence and broader adoption. This challenge can also increase the need for standardization, validation, and quality-control measures before testing becomes routinely integrated into healthcare. Consequently, inconsistent analytical performance may delay clinical translation and restrict the adoption of microbiome testing across laboratories and healthcare settings.

Gut Microbiome Testing Market Opportunities

Standardized Testing Frameworks Could Accelerate Market Expansion

The development of standardized microbiome testing frameworks creates significant potential for broader clinical adoption and commercialization. For instance, in November 2025, the UK Medicines and Healthcare products Regulatory Agency reported an international study involving 23 laboratories across 11 countries, which established minimum quality criteria for microbiome analysis and highlighted the availability of World Health Organization International DNA Gut Reference Reagents. Greater standardization can improve test reliability, strengthen clinical confidence, and support future diagnostic applications.

Gut Microbiome Testing Market Trends

Some of the notable trends in the market are increasing standardization, sequencing accuracy, clinical validation, and quality-focused microbiome analysis.

Rising Standardization of Microbiome Testing Is Likely to Enhance Market Growth

The market is increasingly moving toward standardized testing protocols to improve the reliability and clinical interpretation of microbiome data. For instance, in November 2025, an MHRA-led international study found substantial differences in microbiome analysis across 23 laboratories in 11 countries, including species identification accuracy ranging from 63% to 100% and false-positive rates from 0% to 41%. The findings support greater adoption of standardized quality criteria, which can improve testing confidence and encourage market growth.

Gut Microbiome Testing Market Share

16S rRNA Sequencing Is Positioned to Lead Technology-Based Market

The market is segmented by technology into 16S rRNA sequencing, shotgun metagenomics, meta transcriptomics, and others. Among these technologies, 16S rRNA sequencing is expected to lead because of its established application in microbial identification and gut microbiome research. For instance, in February 2024, PacBio highlighted full-length 16S sequencing using Kinnex kits, reporting an approximately 12-fold increase in throughput and improved species- and strain-level resolution. Such advancements can enhance microbiome profiling capabilities and support continued adoption of 16S rRNA sequencing.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Gut Microbiome Testing Market Analysis by Region

The regions included in the report are North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to lead, supported by strong microbiome research activity, advanced sequencing capabilities, and growing clinical investigation of microbiome-based disease assessment. For instance, in June 2026, EMBL-led researchers analyzed 6,779 gut microbiome profiles from 27 studies and 906 intestinal tissue samples, identifying a robust colorectal cancer-associated microbial signature. Such large-scale research can strengthen clinical applications and support regional market expansion.

Leading Players in the Gut Microbiome Testing Market

Gut Microbiome Testing Market Segmentation

Key Questions Answered in the Gut Microbiome Testing Market Report

• What was the gut microbiome testing market value in 2025?
• What is the gut microbiome testing market forecast outlook for 2026-2035?
• What are the major factors aiding the gut microbiome testing market demand?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major gut microbiome testing market trends?
• Which product is expected to dominate the market segment?
• Which technology is projected to lead the market segment?
• Which sample type is anticipated to drive the market segment?
• Which application is likely to dominate the market segment?
• Which end user is expected to lead the market segment?
• Who are the key players involved in the gut microbiome testing market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

Research Methodology

This report is developed through a robust mixed-methods research design combining:

• Primary Research: Structured discussions with microbiome researchers, clinical laboratory professionals, diagnostic specialists, testing providers, and industry stakeholders to assess testing adoption, technology preferences, clinical applications, and market developments across key regions.
• Secondary Research: Analysis of peer-reviewed research, microbiome studies, regulatory information, and industry publications, including evidence from EMBL-led research, the UK Medicines and Healthcare products Regulatory Agency (MHRA), the World Health Organization (WHO), and PacBio. Sources covering sequencing accuracy, microbiome testing standardization, clinical applications, and testing methodologies were reviewed.
• Validation: Market estimates and qualitative findings are triangulated through top-down and bottom-up assessment, cross-validation of secondary data, analysis of technology and application trends, and expert feedback to improve consistency and reliability.